-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Estrella Immunopharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q1 2021 to Q3 2025.
- Estrella Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 37,096,024, a 2.5% increase year-over-year.
- Estrella Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 27,103,964, a 8765% increase from 2023.
- Estrella Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 305,748.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)